Monitor for any upcoming clinical catalyst (pipeline milestones, data readout) that could move the stock materially; these insider sales are purely liquidity-driven option exercises and convey no directional signal about the business. The neutral read is consistent with prior GLUE reports' poor predictive accuracy for significant moves.
Price Chart
Executive Summary
A cluster of insider sales and option exercises at Monte Rosa Therapeutics over the past week saw Chief Medical Officer Janku Filip exercise and sell 48,000 shares for ~$882K, while the COO and CSO also sold small lots totaling ~$104K. The combined $101K open-market sale value represents ~0.006% of the $1.8B market cap — a trivial amount — and all sales are tied to routine option exercises, not directional bets on the stock.
Key Financial Metrics
Key Facts
- Chief Medical Officer Janku Filip exercised options on 30,000 shares at $0 (grant) and 30,000 at $7.56, then sold 30,000 shares at $21.42 for $643K on June 24.
- CMO also exercised 6,000 at $0 and 6,000 at $7.56, selling 11,845 at $20.22 for $240K on June 23.
- COO Champoux sold 2,175 shares at $20 for $44K and CSO Townson sold 3,000 at $20 for $60K on June 23.
- Total open-market sale value across all insiders is ~$986K — just 0.055% of the $1.8B market cap.
- All sales correspond to standard option exercise-and-sell programs; no unexplained discretionary selling.
- Cross-filing calibration shows all pairwise combo AMPLIFIERs, but the dollar amounts here are too trivial for amplification to change the neutral read.
Financial Impact
Total open-market insider sales of ~$986K, or approximately 0.055% of GLUE's $1.8B market cap — negligible economic impact.
Risk Factors
- Negative historical call P&L suggests the stock tends to underperform after prior reports.
- Biotech sector volatility around data readouts could cause outsized moves regardless of insider activity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GLUE-1782446607027 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 8-K | $11.26 | awaiting T+60 | — | $10.58 (−6.04%) |
Sep 30, 2026 26d ago | Press Release | $11.26 | awaiting T+60 | — | $10.58 (−6.04%) |
Aug 6, 2026 11w ago | 8-K | $15.71 | awaiting T+60 | — | $10.58 (−32.65%) |
Jul 17, 2026 14w ago | Insider Cluster | $23.48 $9.89 | ▼ −57.88% | ▼ −62.72% | $10.58 (−54.94%) |
Jul 7, 2026 15w ago | Insider Cluster | $24.06 $11.93 | ▼ −50.42% | ▼ −52.73% | $10.58 (−56.03%) |
Jul 1, 2026 16w ago | Insider Cluster | $24.21 $11.72 | ▼ −51.59% | ▼ −54.60% | $10.58 (−56.30%) |
Jul 1, 2026 16w ago | Insider Cluster | $24.21 $11.72 | ▼ −51.59% | ▼ −54.60% | $10.58 (−56.30%) |
Jun 29, 2026 17w ago | 144 | $24.20 $11.89 | ▼ −50.87% | ▼ −54.43% | $10.58 (−56.28%) |
Jun 25, 2026 17w ago | Insider Cluster | $22.29 $12.60 | ▼ −43.47% | ▼ −49.56% | $10.58 (−52.53%) |
Jun 2, 2026 20w ago | Insider Cluster | $17.59 $14.32 | ▼ −18.59% | ▼ −21.09% | $10.58 (−39.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers